Parker Waichman LLP

Procrit, Similar Drugs Linked to Increased Death Risk By Two More Studies

Two more studies have found that anemia drugs like Epogen, Procrit and Aranesp raise the risk of death among cancer patients. Despite known safety risks, drugs like Procrit continue to be used because it is believed that they help reduce the number of blood transfusions some cancer patients need, while improving quality of life. According […]

Two more studies have found that anemia drugs like Epogen, <"https://www.yourlawyer.com/topics/overview/procrit">Procrit and Aranesp raise the risk of death among cancer patients. Despite known safety risks, drugs like Procrit continue to be used because it is believed that they help reduce the number of blood transfusions some cancer patients need, while improving quality of life. According to a report on MedicineNet.com, these two studies may raise questions about that theory.

Epogen, Procrit and Aranesp are known as erythropoiesis-stimulating agents (ESAs). ESAs are a bioengineered version of a natural protein made in the kidney that stimulates the bone marrow to produce more red blood cells. They are approved in the U.S. to treat anemia in cancer patients undergoing chemotherapy.

ESAs have long been the subject of safety concerns. Last summer, the Food & Drug Administration (FDA) ordered the labeling changes because several studies have shown that Procrit and other ESAs increased tumor growth and shortened survival time in some cancer patients. Among other things, the agency mandated that the labeling be modified to say that the drugs shouldn’t be used in cancer patients receiving chemotherapy when a cure of their cancer is anticipated.

In the first study, researchers from the University of Alberta, Canada, analyzed data from 52 clinical trials that included more than 12,000 people. According to MedicineNet.com, they found that patients treated with ESAs increased the risk of death and serious adverse events such as blood clots by 15% to 16%.

The report, published in the April 30 online edition of the Canadian Medical Association Journal, concluded that ESAs should not routinely be used as an alternative to blood transfusions in patients with anemia related to cancer.

The second study, published in the May 2 issue of The Lancet, was conducted by scientists at the University of Bern in Switzerland. They looked at the findings from 53 cancer trials that included a total of almost 14,000 patients. More than 1,500 patients died during the study period, and almost 5,000 patients died overall, MediciNet.com said. That translated to a 17% increase in deaths during the study period. Patients undergoing chemotherapy had a 10% increased risk of dying.

The authors wrote that the findings “show that erythropoiesis-stimulating agents increase mortality in all patients with cancer, and a similar increase might exist in patients on chemotherapy.” They advised that the risks of ESA be balanced against the benefits of treatment. They also said more study is needed to address the drugs’ impact on tumor progression and quality of life, MedicineNet.com said.Ticker move Palermo Shooting video

Four Christmases download

Out of Time hd

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Mom died as a result of nursing home negligence.The general consensus was that she was old and near death anyway...so,not worth much monetarily!!!The people at Parker Waichman felt otherwise.They handled the case and treated my sister and myself as though we were their ONLY clients.We were most fortunate to meet the AMAZING Cybele Louis and her team....Stephanie San Filippo and Cindy Custodio.They were sensitive to the needs of our family but also tough with our awful opponents!!!! They accomplished more in a few short months than had been done in six years!!!! I also thank the reception crew who took my endless calls!!!!(Special thanks to Stephanie for putting up with my rants!!!!)
Gail Ratigan
4 years ago
5 Star Reviews 150
Positive: Professionalism , Quality , Responsiveness
Thomas Caragliano
3 years ago
5 Star Reviews 150
Nicole Copertino is the BEST. She is very knowledgeable and helpful. She give a clear understanding of your claim and takes the time to give a caring extra moment if u need it. Which means a lot.
NINA DEAN
2 weeks ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038